Dr. Stephen G. Odaibo
Dr. Stephen G. Odaibo is a Physician, Mathematician, Computer scientist, Neuroscientist, Physicist, and Retina specialist. He won the 2005 Barrie Hurwitz Award for Excellence in Clinical Neurology at Duke University School of Medicine where he topped the class in Neurology. Dr. Odaibo is Chief Scientist and Founder of Quantum Lucid Research Laboratories, a Computational Biotechnology Company. He is also a Retina specialist at the Medical Associates Clinic in Dubuque Iowa. In 2016, he delivered the opening Keynote Address at the Global Ophthalmologists Meeting in Osaka Japan.
Dr. Odaibo obtained a B.S. in Mathematics (UAB, 2001), M.S. in Mathematics (UAB, 2002), M.S. in Computer Science (Duke, 2009), and Doctor of Medicine--MD (Duke, 2010). From 2004 to 2006, Dr. Odaibo was in the lab studying G-protein coupled receptors with Robert J. Lefkowitz, the 2012 Nobel Laureate in Chemistry. Dr. Odaibo completed his Internship in Internal Medicine at Duke University Hospital (Durham) in 2011, his Residency in Ophthalmology at Howard University Hospital (Washington DC) in 2014, and his Fellowship in Medical Retina, Uveitis, and Ocular Oncology at the University of Michigan-Kellogg Eye Center (Ann Arbor) in 2015. He has published textbooks in advanced Mathematics and Physics. He is author of the book, ``Quantum Mechanics and the MRI Machine'' (Symmetry Seed Books, Oct 2012), and of the book "The Form of Finite Groups: A Course on Finite Group Theory" (Symmetry Seed Books, Jan 2016).
Dr. Odaibo has received a number of recognitions and awards. He won the 2013 Best Resident Research Presentation Award at the 23rd Annual Washington Retina Symposium, for devising the Sinc wavelet, a mathematical model describing the behavior of motion-processing neurons. In 2012 he was selected as a Featured Alumnus of the Mathematics Department at UAB. In Oct 2011 his cornea paper was selected by MIT Technology Review as one of the best papers from Physics or Computer science submitted to the arXiv. In that paper, Dr. Odaibo provided the first quantitative demonstration of non-paraxial light bending in the human cornea.
Dr. Odaibo's research interest is Algebraic Structures, a branch of pure Mathematics. His clinical interests are in the diagnosis and Pharmacological/Laser management of retinal disease. The conditions he treats include macular degeneration, diabetic retinopathy, retinal vascular occlusions, retinal tears, and localized retinal detachments. He enjoys taking care of his patients, and feels truly blessed at the opportunity to provide them compassionate, evidence-based, state-of-the-art retina care.
He loves his wife Lisa, his son Daniel, his family and friends, and studying the bible in its rich historical context.
David Odaibo (CTO)
David Odaibo is Chief Technology Officer and Founder of Quantum Lucid Research Laboratories. He graduated from the University of Alabama Birmingham with a degree in Electrical Engineering. He additionally obtained an M.S. degree in applied computer science from Kennesaw University. He is currently pursing a doctoral degree in Computer and Electrical Engineering, with a specialization in Machine Learning . David Odaibo is a software architect with high-level expertise in various development platforms. He has developed multiple software solutions for banking, education, and social media.